Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Amicus Therapeutics Inc’s current trading price is -51.94% away from its 52-week high, while its distance from the 52-week low is 2.62%. The stock’s price range over this period has fluctuated between $5.93 and $12.65. The company, operating within the financial sector, had a trading volume of approximately 8.81 million for the day, which was noticeably higher than the average daily share volume of 3.49 million over the last 3 months.
Amicus Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $12.65 on 11/06/24, while the lowest price for the same period was registered at $5.93 on 05/08/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Amicus Therapeutics Inc (FOLD) has experienced a quarterly decline of -38.15% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.87B and boasts a workforce of 499 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.70, with a change in price of -4.08. Similarly, Amicus Therapeutics Inc recorded 3,039,507 in trading volume during the last 100 days, posting a change of -40.16%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for FOLD stands at 2.29. Similarly, the long-term debt-to-equity ratio is also 2.25.
FOLD Stock Stochastic Average
Today’s raw stochastic average for Amicus Therapeutics Inc over the last 50 days is 7.07%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 13.79%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 8.86% and 12.71%, respectively.
FOLD Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Year to date metric has recorded a loss of -35.46%.However, over the last six months, we can see a stronger performance of -46.34%. Over the last 30 days, the price of FOLD has leaped by -9.52%. And in the last five days, it has fallen by -8.98%.
